Finding biological clues to diagnose psychosis early
Part of Mental health clinical trials.
This study looks for a biological signature in the brain and blood to help doctors tell apart different types of psychosis early on. It may help people with schizophrenia, bipolar disorder, or major depression understand their condition better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with schizophrenia, bipolar disorder, or major depressive disorder.
- You have had a special brain MRI scan (3 Tesla) or are willing to have one.
- You have blood samples available for genetic and inflammation testing, or are willing to give them.
- You do not have a major medical condition like cancer, autoimmune disease, or a brain disorder.
- You are not currently taking medications that affect the immune system (like steroids or strong pain relievers).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system, genetics, inflammation, and past exposures may relate to bipolar disorder or schizophrenia. It may help researchers understand the cause and find better ways to support people with these conditions.
This study builds a database of brain-signal measurements to help find “biomarkers” that may point to schizophrenia or related mental illnesses. Depending on whether you have a mental health diagnosis or you’re healthy, the study will collect information and brain data to compare groups.
This study looks for biological markers in the blood or spinal fluid that might predict how well a new psychiatric treatment will work. If you have a psychiatric condition that hasn't improved with previous treatments, this research could help find better ways to match treatments to individuals in the future.
This study collects information about mental health symptoms and body/genetic samples to better understand how different mental health conditions are related. Some people may also have brain scans (PET or MRI) if they can safely complete them.
This study looks for early warning signs—both mood symptoms and physical/behavior changes—that can help predict unipolar (non-manic) depression in people receiving outpatient care. It may help researchers develop better ways to recognize who is at risk and track symptoms over time.
This study looks at treatment response markers (signs in the body) in people with major depressive disorder (MDD). It may help researchers understand who is more likely to benefit from antidepressant treatment.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.